当前位置：首页 > 文献互助 > 互助详情

Moving from genome-scale to community-scale metabolic models for the human gut microbiome复制

用户9aXbZ8qLNO1o 9小时前 16 10 已完结

1. 当前求助状态已完结, 请及时下载应助文件

2. 系统将在 2025-05-16 11:31:45 删除文件

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1038/s41564-025-01972-2复制

文献链接: https://www.nature.com/articles/s41564-025-01972-2复制

其他信息:

出版社: Springer Science and Business Media LLC
作者: Nick Quinn-Bohmann; Alex V. Carr; Christian Diener; Sean M. Gibbons
全文下载地址: https://www.nature.com/articles/s41564-025-01972-2.pdf

上一篇：Bicalutamide: clinical pharmacokinetics and metabolism

下一篇：FDA Approval Summary: Tovorafenib for Relapsed or Refractory BRAF-Altered Pediatric Low-Grade Glioma

互助时间线

2025-05-09 11:37:40 [完结求助]

楼主确认了jodie0105应助的文件是正确的, 求助状态变成 已完结

2025-05-09 11:31:45 [上传文件]

jodie0105上传了文件(pdf 1.31 MB), 求助状态变成 待确认

2025-05-09 10:46:44 [发起求助]

最新发布的求助

Control theory for partial differential equations 1分钟前
ortho C−H Alkylation of Aryl Chlorides by a Catellani Strategy 51分钟前
Efficacy and safety of ZX-7101A, an inhibitor of influenza cap-dependent endonuclease, in adults with uncomplicated influenza: a randomized, double-blind, placebo-controlled phase 2/3 trial 3小时前
Discovery of cyanoguanidine derivatives as biased μ-opioid receptor agonists 4小时前
Development of small pixel CZT detectors for future hard x-ray missions 5小时前
Repurposing an epithelial sodium channel inhibitor as a therapy for murine and human skin inflammation 6小时前
FDA Approval Summary: Tovorafenib for Relapsed or Refractory BRAF-Altered Pediatric Low-Grade Glioma 9小时前
Moving from genome-scale to community-scale metabolic models for the human gut microbiome 9小时前
Bicalutamide: clinical pharmacokinetics and metabolism 11小时前
A Review on Oils used in Herbal Cosmetics 11小时前
Drug-Polymer Conjugates Containing Acid-Cleavable Bonds 23小时前
Potential alternatives to αβ-T cells to prevent graft-versus-host disease (GvHD) in allogeneic chimeric antigen receptor (CAR)-based cancer immunotherapy: A comprehensive review 1天前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com